People In The News | GenomeWeb

NEW YORK (GenomeWeb News) – Vermillion has tapped Thomas McLain to be president and CEO, replacing interim CEO Bruce Huebner, who will retain his position as a company director.

McLain formerly was CEO and CFO of Claro Scientific, an early-stage diagnostic company, and he held senior management positions at Nabi Biopharmaceuticals and was a member of the board of the Biotechnology Industry Organization.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.

Jeff Huber, former Google X senior vice president, joins Grail as its CEO.

In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.